REQUEST A DEMO
Total
USD $0.00
Search more companies

Oxigenos Del Oriente S.A.S. (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Pharmacies and Drug Stores
Secondary Activities: Chemical and Allied Products Merchant Wholesalers | Scientific Research and Development Services | Electronic and Precision Equipment Repair and Maintenance
Full name: Oxigenos Del Oriente S.A.S. Profile Updated: January 31, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Oxigenos Del Oriente S.A.S. is a company in Colombia, with a head office in Yopal. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. It was incorporated on May 21, 2002. There was a net sales revenue increase of 7.67% reported in Oxigenos Del Oriente S.A.S.’s latest financial highlights for 2025. A negative growth of 5.63% was recorded in its total assets. The net profit margin of Oxigenos Del Oriente S.A.S. decreased by 11.97% in 2025.

Headquarters
Calle 47 N 4 82
Yopal; Casanare;

Contact Details: Purchase the Oxigenos Del Oriente S.A.S. report to view the information.

Basic Information
Registered Capital:
Purchase the Oxigenos Del Oriente S.A.S. report to view the information.
Financial Auditors:
Purchase the Oxigenos Del Oriente S.A.S. report to view the information.
Incorporation Date:
May 21, 2002
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Oxigenos Del Oriente S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
7.67%
Total Operating Revenue
7.67%
Operating Profit
-69.62%
EBITDA
-54.71%
Net Profit/Loss for the Period
-70.73%
Total Assets
-5.63%
Total Equity
-3.75%
Operating Profit Margin
-15.68%
Net Profit Margin
-11.97%
Return on Equity (ROE)
-16.22%
Debt / Equity
13.88%
Quick Ratio
-0.44%
Cash Ratio
-0.05%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?